[Medicines reconciliation at hospital admission into an electronic prescribing program] [0.03%]
[药物一致性核查在医院电子处方项目中的应用]
Lucía Villamayor-Blanco,Leticia Herrero-Poch,Jose Carlos De-Miguel-Bouzas et al.
Lucía Villamayor-Blanco et al.
Objective: To describe and to analyse a new method of integrated medicines reconciliation in an electronic prescribing program results. Method: ...
Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias [0.03%]
硫药治疗血管畸形导致复发性肠出血疗效不佳
María Del Carmen Izquierdo Navarro,Mercedes Hernando Verdugo,Elena Cardaba Garcia et al.
María Del Carmen Izquierdo Navarro et al.
Angiodysplasias are one of the reasons of gastrointestinal bleeding, whose origin is usually due to vascular malformations. There are different types of therapies for angiodysplasia such as endoscopic, angiographic and pharmacological techn...
David Suárez Del Olmo,Laura Corregidor Luna,Francisco José Hidalgo Correas et al.
David Suárez Del Olmo et al.
[Serotonin syndrome associated with the administration of duloxetine; report of a case] [0.03%]
与度洛西汀应用有关的5-羟色胺综合征1例报告
Ramón Fernández Fernández,Edgar Fernández Alonso,Pedro Castro Rebollo et al.
Ramón Fernández Fernández et al.
Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm? [0.03%]
暴露前预防措施防止艾滋病感染：新的预防模式？
Javier Sánchez-Rubio Ferrández,José Manuel Martínez Sesmero
Javier Sánchez-Rubio Ferrández
Pre-exposure prophylaxis" (PrEP) has been recently developed as a prevention strategy which involves the administration of drugs to non-infected individuals who present high exposure or susceptibility to HIV. Although this use is not approv...
Informed consent in clinical research; Do patients understand what they have signed? [0.03%]
临床试验中的知情同意；患者是否理解自己签署的内容？
Elena Villamañán,Margarita Ruano,Enma Fernández-de Uzquiano et al.
Elena Villamañán et al.
Informed consent is an essential element of research, and signing this document is required to conduct most clinical trials. Its aim is to inform patients what their participation in the study will involve. However, increasingly, their comp...
Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism [0.03%]
与低分子肝素和维生素K抗凝剂相比，用于静脉血栓栓塞性疾病治疗及二级预防的阿哌沙班的成本效益分析
Isabel Elías,Itziar Oyagüez,Luis Antonio Alvarez-Sala et al.
Isabel Elías et al.
Objective: Cost-effectiveness analysis of a 6-month treatment of apixaban (10 mg/12h, first 7 days; 5 mg/12h afterwards) for the treatment of the first event of venous thromboembolism (VTE) and prevention of recurrences, ...
Carmen Caballero Requejo,Elena Urbieta Sanz,Abel Trujillano Ruiz et al.
Carmen Caballero Requejo et al.
Objectives: To analyze if the hypoglycemic therapy prescribed in the Emergency Department adapts to the consensus recommendations available, as well as to assess its clinical impact. ...
Comparison of the traditional pharmaceutical validation method versus an assisted pharmaceutical validation in hospitalized patients [0.03%]
传统药物验证方法与辅助药物验证在住院患者中的比较研究
D García Marco,M V Hernández Sánchez,S Sanz Márquez et al.
D García Marco et al.
Objective: To analyze pharmaceutical interventions that have been carried out with the support of an automated system for validation of treatments vs. the traditional method without computer support. ...
Beers versus STOPP criteria in polyharmacy community-dwelling older patients [0.03%]
聚用药社区老年人中《谨慎使用处方药》标准与《药物-停用》标准的比较
Maria Luisa Nicieza-Garcia,Maria Esther Salgueiro-Vázquez,Francisco José Jimeno-Demuth et al.
Maria Luisa Nicieza-Garcia et al.
Objective: To assess potentially inappropriate prescribing (PIP) using Beers (2012 version) and STOPP (2008 version) criteria in polypharmacy, community-dwelling, older patients. ...